Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia

BACKGROUND: The most advanced dengue vaccine candidate is a live-attenuated recombinant vaccine containing the four dengue viruses on the yellow fever vaccine backbone (CYD-TDV) developed by Sanofi Pasteur. Several analyses have been published on the safety and immunogenicity of the CYD-TDV vaccine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Dorigatti, Ilaria, Aguas, Ricardo, Donnelly, Christl A., Guy, Bruno, Coudeville, Laurent, Jackson, Nicholas, Saville, Melanie, Ferguson, Neil M.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504002/
https://ncbi.nlm.nih.gov/pubmed/26051515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.05.059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados